A detailed history of Bard Associates Inc transactions in Viemed Healthcare, Inc. stock. As of the latest transaction made, Bard Associates Inc holds 345,052 shares of VMD stock, worth $2.96 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares
345,052
Previous 341,290 1.1%
Holding current value
$2.96 Million
Previous $2.24 Million 13.15%
% of portfolio
0.95%
Previous 0.93%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$6.3 - $7.6 $23,700 - $28,591
3,762 Added 1.1%
345,052 $2.53 Million
Q2 2024

Aug 12, 2024

SELL
$6.32 - $9.38 $5,846 - $8,676
-925 Reduced 0.27%
341,290 $2.24 Million
Q1 2024

May 13, 2024

BUY
$7.29 - $9.99 $28,285 - $38,761
3,880 Added 1.15%
342,215 $3.23 Million
Q4 2023

Feb 13, 2024

BUY
$6.04 - $8.45 $1.84 Million - $2.57 Million
303,880 Added 881.96%
338,335 $2.66 Million
Q3 2023

Nov 13, 2023

BUY
$6.73 - $9.85 $70,866 - $103,720
10,530 Added 44.01%
34,455 $231,000
Q2 2023

Aug 11, 2023

SELL
$9.2 - $11.77 $625 - $800
-68 Reduced 0.28%
23,925 $233,000
Q1 2023

May 12, 2023

BUY
$7.55 - $10.2 $7,550 - $10,200
1,000 Added 4.35%
23,993 $231,000
Q4 2022

Feb 10, 2023

BUY
$5.66 - $7.63 $11,320 - $15,260
2,000 Added 9.53%
22,993 $173,000
Q3 2022

Nov 09, 2022

BUY
$5.43 - $7.96 $543 - $796
100 Added 0.48%
20,993 $126,000
Q2 2022

Aug 11, 2022

BUY
$4.94 - $5.81 $14,820 - $17,430
3,000 Added 16.77%
20,893 $112,000
Q1 2022

May 11, 2022

BUY
$3.58 - $5.55 $601 - $932
168 Added 0.95%
17,893 $89,000
Q3 2021

Nov 12, 2021

BUY
$5.55 - $7.4 $11,100 - $14,800
2,000 Added 12.72%
17,725 $98,000
Q2 2021

Aug 12, 2021

BUY
$7.15 - $10.34 $112,433 - $162,596
15,725 New
15,725 $112,000

Others Institutions Holding VMD

About VIEMED HEALTHCARE, INC.


  • Ticker VMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 38,222,000
  • Market Cap $328M
  • Description
  • Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, per...
More about VMD
Track This Portfolio

Track Bard Associates Inc Portfolio

Follow Bard Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bard Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bard Associates Inc with notifications on news.